Angioplasty and Stenting versus Carotid-Subclavian Bypass for the Treatment of Isolated Subclavian Artery Disease

Abstract

Purpose:

To compare the results of a large series of percutaneous transluminal angioplasty (PTA)/stenting procedures in the subclavian artery with the results of a series of carotid-subclavian by pass grafts (CSBG) performed at the same institution for subclavian artery disease.

Methods:

Between 1993 and 2006, 121 patients (43 men; mean age 63 years, range 38–85) underwent subclavian artery PTA/stenting and were compared to a group of 51 patients (29 men; mean age 62 years, range 46–75) with isolated subclavian artery occlusive disease treated with CSBG using polytetrafluoroethylene grafts. Graft or PTA/stenting patency was determined clinically and confirmed by Doppler pressures and/or duplex ultrasound/angiography. The cumulative patency and overall survival rates were calculated using the life-table method.

Results:

The mean follow-up for the PTA/stent group was 3.4 years versus 7.7 years for the CSBG group. The technical success rate for the CSBG group was 100% versus 98% (119/121) for the PTA/stent group. The overall perioperative complication rate in the stent group was 15.1% (18/119: 11 minor and 7 major complications) versus 5.9% (3/51: 2 phrenic nerve palsy and 1 myocardial infarction) in the bypass group (p=0.093). There was no perioperative stroke or mortality in the CSBG group. The major perioperative complications in the stent group included 4 thromboembolic events, 1 congestive heart failure, 1 reperfusion arm edema, and 1 pseudoaneurysm. There was 1 perioperative death in the stent group. The 30-day patency rate was 100% for the bypass group and 97% (118/121) for the PTA/stent group. The primary patency rates at 1, 3, and 5 years were 100%, 98%, and 96% for the CSBG group versus 93%, 78%, and 70% for the stent group, respectively (p<0.0001). Freedom from symptom recurrence was also statistically superior in the bypass group versus the stent group (p<0.0001). There were no significant differences in the survival rates between both groups at any time point (p=0.322).

Conclusion:

Both CSBGs using PTFE grafts and subclavian PTA/stenting are safe, effective, and durable; however, CSBG is more durable in the long term. PTA/stenting of the subclavian artery should be the procedure of choice for high-risk patients; however, CSBG should be offered to good-risk surgical candidates who may be seeking a more durable procedure.

Keywords

subclavian artery balloon angioplasty stent carotid-subclavian bypass graft comparative study morbidity mortality

Get full access to this article

View all access options for this article.

References

Bachman

Kim

. Transluminal dilatation for subclavian steal syndrome. AJR Am J Roentgenol. 1980; 135: 995–996.

Hebrang

Maskovic

Tomac

. Percutaneous transluminal angioplasty of the subclavian arteries: Long-term results in 52 patients. AJR Am J Roentgenol. 1991; 156: 1091–1094.

Motarjeme

. Percutaneous transluminal angioplasty of supra-aortic vessels. J Endovasc Surg. 1996; 3: 171–181.

Henry

Amor

Henry

. Percutaneous transluminal angioplasty of the subclavian arteries. J Endovasc Surg. 1999; 6: 33–41.

Rodriquez-Lopez

Werner

Martinez

. Stenting for atherosclerotic occlusive disease of the subclavian artery. Ann Vasc Surg. 1999; 13: 254–260.

de Vries

Jager

van den Berg

. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: Long-term results. J Vasc Surg. 2005; 41: 19–23.

Woo

Fairman

Velazquez

. Endovascular therapy of symptomatic innominate-subclavian arterial occlusive lesions. Vasc Endovasc Surg. 2006; 40: 27–33.

Przewlocki

Kablak-Ziembicka

Pieniazek

. Determinants of immediate and long-term results of subclavian and innominate artery angioplasty. Catheter Cardiovasc Intervent. 2006; 67: 519–526.

Farina

Mingoli

Schultz

. Percutaneous transluminal angioplasty versus surgery for subclavian artery occlusive disease. Am J Surg. 1989; 158: 511–514.

10.

Ballotta

Da Diau

Abbruzzese

. Subclavian carotid transposition for symptomatic subclavian artery stenosis or occlusion: A comparison with the endovascular procedure. Int Angiol. 2002; 21: 138–144.

11.

Modari

Ali

Dourado

. Comparison of extra-anatomic bypass grafting with angioplasty for atherosclerotic disease of the supra-aortic trunks. Brit J Surg. 2004; 91: 1453–1145.

12.

Bates

Broce

Lavigne

. Subclavian artery stenting: Factors influencing long-term outcome. Catheter Cardiovasc Interv. 2004; 61: 5–11.

13.

Debakey

Morris

Jordan

. Segmental thrombo-obliterative disease of branches of the aortic arch. JAMA. 1958; 166: 988–1003.

14.

Diethrich

Garret

Ameriso

. Occlusive disease of the common carotid and subclavian arteries treated by carotid-subclavian bypass. Am J Surg. 1967; 114: 800–809.

15.

Moore

Malone

Goldstone

. Extra-thoracic repair of branch occlusion of the aortic arch. Am J Surg. 1976; 132: 249–257.

16.

Raithel

. Our experience of surgery of innominate and subclavian lesions. J Cardiovasc Surg. 1980; 21: 423–430.

17.

Crawford

Stowe

Powers

. Occlusion of the innominate, common carotid, and subclavian arteries: Long-term results of surgical treatment. Surgery. 1983; 94: 781–791.

18.

Ziomek

Quinones-Baldrich

Busuttil

. The superiority of synthetic arterial grafts over autogenous veins in carotid-subclavian bypass. J Vasc Surg. 1986; 106: 140–145.

19.

Sterpetti

Schultz

Farina

. Subclavian artery revascularization: A comparison between carotid-subclavian bypass and carotid transposition. Surgery. 1989; 106: 624–632.

20.

Perler

Williams

. Carotid-subclavian bypass — A decade of experience. J Vasc Surg. 1990; 12: 716–723.

21.

Vitti

Thompson

Rad

. Carotid-subclavian bypass: A twenty-two year experience. J Vasc Surg. 1994; 20: 411–418.

22.

AbuRahma

Robinson

Jennings

. Carotid-subclavian bypass grafting with polytetrafluoroethylene grafts for symptomatic subclavian artery stenosis or occlusion: A 20-year experience. J Vasc Surg. 2000; 32: 411–419.